# BillionToOne

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/billiontoone

- Industry: Biotechnology
- Headquarters: Menlo Park, US
- Website: www.billiontoone.com/
- Total disclosed funding: $343M
- Latest round: Series D (Jun 21, 2024)
- Investors on record: 16

## About

Based in California, US, and founded in 2016 by co-founders Oguzhan Atay, Ph.D. (CEO), David Tsao, Ph.D., and Sukrit Silas, Ph.D., BillionToOne, Inc. operates as a provider of non-invasive prenatal testing through molecular counting of DNA done on blood samples. In June 2024, BillionToOne, Inc. raised USD 130 million in Series D funding led by Premji Invest, with participation from Neuberger Berman, Adam Street Partners, Baillie Gifford, Civilization Ventures, Fifty Years, Hummingbird Ventures, and Libertus Capital.

The company provides a wide range of molecular diagnostic products, such as UNITY Screen for non-invasive prenatal screening and Northstar Select and Northstar Response for liquid biopsy. Additionally, the firm also provides services such as therapeutic response monitoring using methylation assessment.

## Funding rounds

- Series D, Jun 21, 2024, $130M — Adams Street Partners, Hummingbird Ventures, Premji Invest, Baillie Gifford, Neuberger Berman, Civilization Ventures, Fifty Years, Libertus Capital
- Series C, Mar 16, 2022, $125M — Adams Street Partners, Norwest Venture Partners, Hummingbird Ventures, Baillie Gifford, 500 Global, NeoTribe Ventures, Civilization Ventures, Fifty Years, Libertus Capital, Pacific 8 Ventures, Time BioVentures
- Series B, Jun 15, 2021, $55M — Norwest Venture Partners, Hummingbird Ventures, 500 Global, Four Rivers Group, Y Combinator, NeoTribe Ventures, Libertus Capital
- Series A, Mar 10, 2020, $15M — Hummingbird Ventures, 500 Global, HOF Capital, NeoTribe Ventures, Civilization Ventures, Libertus Capital, Pacific 8 Ventures
- Series A, Mar 13, 2019, $18M — Hummingbird Ventures, 500 Global, Y Combinator, HOF Capital, NeoTribe Ventures, Civilization Ventures, Fifty Years

## Investors

- Hummingbird Ventures (https://capitalatlas.ai/funds/hummingbird-ventures) — Series A, Series B, Series C, Series D
- 500 Global (https://capitalatlas.ai/funds/500-global) — Series A, Series B, Series C
- Y Combinator (https://capitalatlas.ai/funds/y-combinator) — Series A, Series B
- HOF Capital (https://capitalatlas.ai/funds/hof-capital) — Series A
- NeoTribe Ventures (https://capitalatlas.ai/funds/neotribe-ventures) — Series A, Series B, Series C
- Civilization Ventures (https://capitalatlas.ai/funds/civilization-ventures) — Series A, Series C, Series D
- Fifty Years (https://capitalatlas.ai/funds/fifty-years) — Series A, Series C, Series D
- Libertus Capital (https://capitalatlas.ai/funds/libertus-capital) — Series A, Series B, Series C, Series D
- Pacific 8 Ventures — Series A, Series C
- Norwest Venture Partners (https://capitalatlas.ai/funds/norwest-venture-partners) — Series B, Series C
- Four Rivers Group (https://capitalatlas.ai/funds/four-rivers-group) — Series B
- Adams Street Partners (https://capitalatlas.ai/funds/adams-street-partners) — Series C, Series D
- Baillie Gifford (https://capitalatlas.ai/funds/baillie-gifford) — Series C, Series D
- Time BioVentures (https://capitalatlas.ai/funds/time-bioventures) — Series C
- Premji Invest — Series D
- Neuberger Berman (https://capitalatlas.ai/funds/neuberger-berman) — Series D